Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCL

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02232516
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:50.793338+00:00
Published At
2024-04-10T00:00:00+00:00
Record Updated At
2024-04-10
Results Posted At
2024-04-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Hepatosplenic T-cell Lymphoma", "Peripheral T-cell Lymphoma", "Stage I Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IA Mycosis Fungoides/Sezary Syndrome", "Stage IB Mycosis Fungoides/Sezary Syndrome", "Stage II Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IIA Mycosis Fungoides/Sezary Syndrome", "Stage IIB Mycosis Fungoides/Sezary Syndrome", "Stage III Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IIIA Mycosis Fungoides/Sezary Syndrome", "Stage IIIB Mycosis Fungoides/Sezary Syndrome", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IVA Mycosis Fungoides/Sezary Syndrome", "Stage IVB Mycosis Fungoides/Sezary Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-04-10"
protocolSection.identificationModule.nctId
"NCT02232516"
protocolSection.identificationModule.officialTitle
"Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCL"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-04-10"

Study condition terms

  • Adult Nasal Type Extranodal NK/T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Hepatosplenic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Peripheral T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage II Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IIA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IIB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage III Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IIIB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Stage IVB Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.